TrialClinical and translational science2021

Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study.

Hari V Kalluri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.